CalciMedica Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CALC Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
06 Dec 24	BuyUS$12,720	Fred Middleton	Individual	4,800	US$2.65
01 Nov 24	BuyUS$199,999	Eric Roberts	Individual	53,333	US$3.75
01 Nov 24	BuyUS$75,000	A. Leheny	Individual	20,000	US$3.75
01 Nov 24	BuyUS$199,999	Robert Wilson	Individual	53,333	US$3.75
01 Nov 24	BuyUS$329,040	Sanderling Ventures	Company	87,744	US$3.75
01 Nov 24	BuyUS$75,000	Fred Middleton	Individual	20,000	US$3.75
27 Aug 24	BuyUS$4,190	A. Leheny	Individual	1,000	US$4.19
23 Aug 24	BuyUS$17,867	Eric Roberts	Individual	5,000	US$3.58
23 Aug 24	BuyUS$200,826	Robert Wilson	Individual	54,000	US$3.72
21 Aug 24	BuyUS$20,200	Eric Roberts	Individual	5,000	US$4.04
28 Jun 24	BuyUS$180,499	Robert Wilson	Individual	51,278	US$3.52
27 Jun 24	BuyUS$27,305	Robert Wilson	Individual	8,443	US$3.23
27 Jun 24	BuyUS$16,100	Eric Roberts	Individual	5,000	US$3.22
02 Apr 24	BuyUS$15,600	CIBC World Markets Corp., Brokerage and Security Investments	Company	4,000	US$3.90
23 Jan 24	BuyUS$2,515,080	Sanderling Ventures	Company	679,384	US$3.70

Insider Trading Volume

Insider Buying: CALC insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CALC?
Owner Type	Number of Shares	Ownership Percentage
Hedge Funds	1,783,904	13.2%
General Public	2,236,839	16.6%
Institutions	2,349,402	17.4%
VC/PE Firms	3,146,498	23.3%
Individual Insiders	3,965,274	29.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 137.2%.

Top Shareholders

Top 25 shareholders own 82.17% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.9%	Sanderling Ventures	2,407,172	US$7.9m	0%	42.54%
17.9%	Timothy Mills	2,407,172	US$7.9m	0%	no data
7.42%	Deerfield Management Company, L.P. Series C	1,000,000	US$3.3m	0%	0.07%
5.81%	Soleus Capital Management, L.P.	783,904	US$2.6m	0%	0.22%
5.48%	Valence Life Sciences	739,326	US$2.4m	0%	100.0%
4.02%	Revelation Capital Management, LLC	542,029	US$1.8m	0%	100.0%
3.87%	Aisling Capital Management LP	521,114	US$1.7m	0%	0.65%
3.56%	Stonepine Capital Management LLC	480,400	US$1.6m	0%	0.6%
3.48%	Laurence Lytton	468,943	US$1.5m	-5.24%	no data
3.1%	Robert Wilson	417,529	US$1.4m	14.6%	no data
1.89%	The Vanguard Group, Inc.	254,148	US$836.1k	0.53%	no data
1.42%	Eric Roberts	191,590	US$630.3k	5.18%	no data
1.14%	BML Capital Management, LLC	153,887	US$506.3k	-4.07%	0.29%
0.98%	A. Leheny	131,926	US$434.0k	17.9%	no data
0.67%	Frederic Guerard	90,727	US$298.5k	0%	no data
0.56%	Braden Leonard	75,000	US$246.7k	0%	no data
0.49%	Geode Capital Management, LLC	66,553	US$219.0k	51.2%	no data
0.41%	Millennium Management LLC	55,233	US$181.7k	-10.3%	no data
0.35%	CIBC World Markets Corp., Brokerage and Security Investments	46,894	US$154.3k	17.6%	no data
0.34%	Meritage Portfolio Management, Inc.	46,000	US$151.3k	0%	0.01%
0.34%	Sudarshan Hebbar	46,000	US$151.3k	0%	no data
0.33%	Fred Middleton	44,690	US$147.0k	125%	no data
0.32%	Envestnet Asset Management, Inc.	43,631	US$143.5k	96%	no data
0.26%	Robert Breuil	35,326	US$116.2k	0%	no data
0.21%	Parisa Zamiri	28,982	US$95.4k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/03 06:20
End of Day Share Price	2025/01/03 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CalciMedica, Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Joseph Pantginis	H.C. Wainwright & Co.
Catherine Novack	JonesTrading Institutional Services, LLC
Leland Gershell	Oppenheimer & Co. Inc.